Prodigen (CEO Shim Soo-ja) announced that it will participate in the 3th International Medical Equipment and Hospital Equipment Exhibition ‘KIMES 23’, which will be held at COEX, Seoul from March 26rd (Thursday) to 38th (Sunday).
Prodigen is a company that has accumulated expertise and know-how in the development and production of Platelet Rich Plasma (PRP) tubes for more than 2008 years since 10. Prodigen’s PRP tube has contributed to the evaluation and certification of many new medical technologies in the domestic medical community, such as being used for PRP injection during embryo transplantation and PRP injection during rotator cuff surgery. Furthermore, last year, it obtained US FDA certification, once again proving its excellence in quality.
At this exhibition, Prodigen presents its PRP tube product line. These products, which are released under strict quality control at our own production facilities, are characterized by fast separation and concentration speeds, such as concentrating large quantities of platelets in just 3 minutes. The official explains that in recognition of its outstanding functionality, overseas sales last year doubled compared to the previous year.
A Prodigen official said, “Platelet-rich plasma has been used in various fields for a long time and its potential has been recognized. However, the existing method of extracting PRP was inconvenient, and the difference in platelet recovery rates between skilled and unskilled people was bound to be large,” he said. “Therefore, we wanted to develop a PRP kit that anyone can extract easily and conveniently.” Background to product development revealed.
Currently, Prodigen plans to expand its global market area in the future by further proceeding with the Chinese FDA approval process for PRP tubes. In addition, we plan to continue developing new products through technological advancement. An official said, “We are very proud that our global sales grew in earnest last year after previously obtaining approval from the U.S. FDA, and that our safety has been recognized worldwide. “We will expand our influence further by introducing more diverse products to the global market in the future,” he said.
He added, “The products being planned first include the ‘Stromal Vascual Fraction (SVF)’ kit and bone marrow processing equipment.”
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.